Ethyl 2-methoxy-5-(trifluoromethyl)nicotinate, 98%, 1g

3-CYCLOPROPYLPROP-2-YN-1-OL, 95.0%, 100g

N2-Ethylpyrimidine-2,5-diamine, 1g

4-(2,2-Bis(4-methoxyphenyl)-1-phenylvinyl)benzaldehyde, 98%, 250mg

2,4-Dichlorobenzene-1,3-diol, 95.0%, 10g

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(thiophen-3-yl)propanoic acid, 95.0%, 5g

6-Amino-2-(butylamino)-9-[[6-[2-(dimethylamino)ethoxy]-3-pyridinyl]methyl]-7,9-dihydro-8H-purin-8-one, 10mg

1-Benzyl-1 H -indole-3-carbaldehyde, 95%, 5g

2-Chloro-N,N-dimethylacetamide, 97.0%, 10g

1-(4-Chlorophenyl)-1H-pyrrole-2-carbaldehyde, 90.0%, 5g

m-Toluylsäure, 98 %, zur Synthese, 250 g, kunststoffverpackung.

4-{3-[4-(Trifluoromethyl)phenyl]-1H-pyrazol-4-yl}pyridine, 95.0%, 10g

Methyl 4-morpholinecarbodithioate, 95+%, 1g